PD
Pacific Diabetes Technologies, Inc.
SEC filingBiotechnology · Portland, OR
Amount raised$3.4Msold at filing
Total offering$3.5M$115K still open
Investors in the raise15count reported to the SEC
FiledNov 17, 2025first sale Oct 6, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Thomas SeidlExecutive Officer, Director, Promoter
Hank WuhDirector
Christopher MarshDirector
Executive officers, directors and promoters as listed on the Form D.